Protocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation

World Journal of Gastroenterology

Volumn 20, Issue 21, 2014, Pages 6638-6650

  Sanada, Yukihiro ^a   Matsumoto, Koshi ^a   Urahashi, Taizen ^a   Ihara, Yoshiyuki ^a   Wakiya, Taiichi ^a   Okada, Noriki ^a   Yamada, Naoya ^a   Hirata, Yuta ^a   Mizuta, Koichi ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Ebina General Hospital   (Japan)

Author keywords

Graft fibrosis; Immunosuppression; Liver function test; Pediatric liver transplantation; Protocol liver biopsy

Indexed keywords

ALANINE AMINOTRANSFERASE; CEFOPERAZONE PLUS SULBACTAM; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ARTICLE; CHILD; CHOLANGITIS; COLD ISCHEMIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT FIBROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; PEDIATRICS; POSTOPERATIVE CARE; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; YOUNG ADULT; BIOPSY; CANCER STAGING; FIBROSIS; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROSIS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; NEOPLASM STAGING; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 84902097382     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i21.6638     Document Type: Article

References (36)

1. Ueda M, Oike F, Ogura Y, Uryuhara K, Fujimoto Y, Kasahara M, Ogawa K, Kozaki K, Haga H, Tanaka K. Long-term outcomes of 600 living donor liver transplants for pediatric patients at a single center. Liver Transpl 2006; 12: 1326-1336 [PMID: 16773638 DOI: 10.1002/lt.20826]
2. Wallot MA, Mathot M, Janssen M, Hölter T, Paul K, Buts JP, Reding R, Otte JB, Sokal EM. Long-term survival and late graft loss in pediatric liver transplant recipients--a 15-year single-center experience. Liver Transpl 2002; 8: 615-622 [PMID: 12089716 DOI: 10.1053/jlts.2002.34149]
3. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, McDiarmid S, Cohen G, Anand R. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry. Pediatrics 2008; 122: e1128-e1135 [PMID: 19047213 DOI: 10.1542/ peds.2008-1363]
4. Evans HM, Kelly DA, McKiernan PJ, Hübscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43: 1109-1117 [PMID: 16628633 DOI: 10.1002/hep.21152]
5. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, Devictor D, Durand P, Baujard C, Fabre M, Pariente D, Chardot C, Dousset B, Massault PP, Bernard D, Houssin D, Bernard O, Gauthier F, Soubrane O. Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 2005; 11: 152-160 [PMID: 15666395 DOI: 10.1002/lt.20358]
6. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS. Graft fibrosis after pediatric liver transplantation: ten years of follow- up. Hepatology 2009; 49: 880-886 [PMID: 19101912 DOI: 10.1002/hep.22686]
7. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 2008; 14: 1582-1587 [PMID: 18975292 DOI: 10.1002/ lt.21549]
8. Ueno T, Tanaka N, Ihara Y, Takama Y, Yamada H, Mushiake S, Fukuzawa M. Graft fibrosis in patients with biliary atresia after pediatric living-related liver transplantation. Pediatr Transplant 2011; 15: 470-475 [PMID: 21771230 DOI: 10.1111/j.1399-3046.2011.01483.x]
9. Gibelli NE, Tannuri U, Mello ES, Cançado ER, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Pinho- Apezzato ML, Maksoud JG. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation. Pediatr Transplant 2006; 10: 371-376 [PMID: 16677364 DOI: 10.1111/j.1399-3046.2005.00470.x]
10. Foster PF, Sankary HN, Williams JW, Bhattacharyya A, Coleman J, Ashmann M. Morphometric inflammatory cell analysis of human liver allograft biopsies. Transplantation 1991; 51: 873-876 [PMID: 2014546 DOI: 10.1097/00007890-199 104000-00026]
11. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293 [PMID: 8690394 DOI: 10.1002/hep.510240201]
12. Sebagh M, Rifai K, Féray C, Yilmaz F, Falissard B, Roche B, Bismuth H, Samuel D, Reynès M. All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology 2003; 37: 1293-1301 [PMID: 12774007 DOI: 10.1053/jhep.2003.50231]
13. Mells G, Neuberger J. Protocol liver allograft biopsies. Transplantation 2008; 85: 1686-1692 [PMID: 18580457 DOI: 10.1097/TP.0b013e318176b1fd]
14. Mells G, Mann C, Hubscher S, Neuberger J. Late protocol liver biopsies in the liver allograft: a neglected investigation? Liver Transpl 2009; 15: 931-938 [PMID: 19642126 DOI: 10.1002/lt.21781]
15. Abraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests. Am J Surg Pathol 2008; 32: 965-973 [PMID: 18460980 DOI: 10.1097/PAS.0b013e3181622490]
16. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699 [PMID: 7560864 DOI: 10.1016/0168-8278(95)80226-6]
17. Venturi C, Sempoux C, Bueno J, Ferreres Pinas JC, Bourdeaux C, Abarca-Quinones J, Rahier J, Reding R. Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant 2012; 12: 2986-2996 [PMID: 22882699 DOI: 10.1111/ j.1600-6143.2012.04210.x]
18. Egawa H, Miyagawa-Hayashino A, Haga H, Teramukai S, Yoshizawa A, Ogawa K, Ogura Y, Okamoto S, Kaido T, Uemoto S. Non-inflammatory centrilobular sinusoidal fibrosis in pediatric liver transplant recipients under tacrolimus withdrawal. Hepatol Res 2012; 42: 895-903 [PMID: 22524409 DOI: 10.1111/j.1872-034X.2012.01003.x]
19. Miyagawa-Hayashino A, Yoshizawa A, Uchida Y, Egawa H, Yurugi K, Masuda S, Minamiguchi S, Maekawa T, Uemoto S, Haga H. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts. Liver Transpl 2012; 18: 1333-1342 [PMID: 22888064 DOI: 10.1002/lt.23534]
20. Gelson W, Hoare M, Unitt E, Palmer C, Gibbs P, Coleman N, Davies S, Alexander GJ. Heterogeneous inflammatory changes in liver graft recipients with normal biochemistry. Transplantation 2010; 89: 739-748 [PMID: 20134396 DOI: 10.1097/TP.0b013e3181c96b32]
21. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481 [PMID: 10960438 DOI: 10.1053/jhep.2000.16602]
22. Tomita H, Hoshino K, Fuchimoto Y, Ebinuma H, Ohkuma K, Tanami Y, Du W, Masugi Y, Shimojima N, Fujino A, Kano M, Fujimura T, Ishihama H, Shimizu T, Tanabe M, Saito H, Sakamoto M, Hibi T, Kitagawa Y, Kuroda T. Acoustic radiation force impulse imaging for assessing graft fibrosis after pediatric living donor liver transplantation: a pilot study. Liver Transpl 2013; 19: 1202-1213 [PMID: 23894066 DOI: 10.1002/lt.23708]
23. Goldschmidt I, Stieghorst H, Munteanu M, Poynard T, Schlue J, Streckenbach C, Baumann U. The use of transient elastography and non-invasive serum markers of fibrosis in pediatric liver transplant recipients. Pediatr Transplant 2013; 17: 525-534 [PMID: 23802661 DOI: 10.1111/petr.12116]
24. Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A, Daskal I, El-Monayeri MS, Fontes P, Fung J, Gridelli B, Guido M, Haga H, Hart J, Honsova E, Hubscher S, Itoh T, Jhala N, Jungmann P, Khettry U, Lassman C, Ligato S, Lunz JG, Marcos A, Minervini MI, Mölne J, Nalesnik M, Nasser I, Neil D, Ochoa E, Pappo O, Randhawa P, Reinholt FP, Ruiz P, Sebagh M, Spada M, Sonzogni A, Tsamandas AC, Wernerson A, Wu T, Yilmaz F. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489-501 [PMID: 16871565 DOI: 10.1002/hep.21280]
25. Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Uemoto S, Manabe T. Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome. Transpl Int 2009; 22: 303-312 [PMID: 19040488 DOI: 10.1111/j.1432-2277.2008.00803.x]
26. Hübscher SG. What is the long-term outcome of the liver allograft? J Hepatol 2011; 55: 702-717 [PMID: 21426919 DOI: 10.1016/j.jhep.2011.03.005]
27. Krasinskas AM, Ruchelli ED, Rand EB, Chittams JL, Furth EE. Central venulitis in pediatric liver allografts. Hepatology 2001; 33: 1141-1147 [PMID: 11343242 DOI: 10.1053/ jhep.2001.23938]
28. Herzog D, Soglio DB, Fournet JC, Martin S, Marleau D, Alvarez F. Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl 2008; 14: 946-955 [PMID: 18581476 DOI: 10.1002/lt.21444]
29. Nagai S, Ito M, Kamei H, Nakamura T, Ando H, Kiuchi T. Indirect immunohistochemical evaluation of graft fibrosis and interface hepatitis after pediatric liver transplantation. Pediatr Transplant 2010; 14: 342-350 [PMID: 19744282 DOI: 10.1111/j.1399-3046.2009.01234.x]
30. Hübscher S. What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl 2009; 15 Suppl 2: S19-S24 [PMID: 19877293 DOI: 10.1002/lt.21902]
31. Al-Sinani S, Dhawan A. Corticosteroids usage in pediatric liver transplantation: To be or not to be! Pediatr Transplant 2009; 13: 160-170 [PMID: 19037913 DOI: 10.1111/ j.1399-3046.2008.01043.x]
32. Diem HV, Sokal EM, Janssen M, Otte JB, Reding R. Steroid withdrawal after pediatric liver transplantation: a long-term follow-up study in 109 recipients. Transplanta- tion 2003; 75: 1664-1670 [PMID: 12777853 DOI: 10.1097/01. TP.0000063938.49112.C2]
33. Campsen J, Zimmerman MA, Trotter JF, Wachs M, Bak T, Steinberg T, Kaplan M, Wright F, Kam I. Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal. Liver Transpl 2008; 14: 1281-1286 [PMID: 18756454 DOI: 10.1002/lt.21525]
34. Trouillot TE, Shrestha R, Kam I, Wachs M, Everson GT. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Liver Transpl Surg 1999; 5: 375-380 [PMID: 10477838 DOI: 10.1002/lt.500050514]
35. Junge G, Neuhaus R, Schewior L, Klupp J, Guckelberger O, Langrehr JM, Tullius S, Neuhaus P. Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis. Transplant Proc 2005; 37: 1695-1696 [PMID: 15919434 DOI: 10.1016/j.tra nsproceed.2005.03.145]
36. Klupp J, Pfitzmann R, Langrehr JM, Neuhaus P. Indications of mycophenolate mofetil in liver transplantation. Transplantation 2005; 80: S142-S146